Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 3
2017 1
2018 2
2019 6
2020 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Neuroendocrine Carcinoma, Excluding Head and Neck"
Page 1
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Kim S, Wuthrick E, Blakaj D, Eroglu Z, Verschraegen C, Thapa R, Mills M, Dibs K, Liveringhouse C, Russell J, Caudell JJ, Tarhini A, Markowitz J, Kendra K, Wu R, Chen DT, Berglund A, Michael L, Aoki M, Wang MH, Hamaidi I, Cheng P, de la Iglesia J, Slebos RJ, Chung CH, Knepper TC, Moran-Segura CM, Nguyen JV, Perez BA, Rose T, Harrison L, Messina JL, Sondak VK, Tsai KY, Khushalani NI, Brohl AS. Kim S, et al. Lancet. 2022 Sep 24;400(10357):1008-1019. doi: 10.1016/S0140-6736(22)01659-2. Epub 2022 Sep 12. Lancet. 2022. PMID: 36108657 Free PMC article. Clinical Trial.
BACKGROUND: Merkel cell carcinoma is among the most aggressive and lethal of primary skin cancers, with a high rate of distant metastasis. ...Grade 3 or 4 treatment-related adverse events were observed in 10 (40%) of 25 patients in group A and 8 (32%) of 25 patients …
BACKGROUND: Merkel cell carcinoma is among the most aggressive and lethal of primary skin cancers, with a high rate of distant metast …
Clinical outcome and comparison between squamous and non-squamous cell carcinoma of the larynx.
Chen L, Deng W, Li C, Lau H, Tao L, Wang S, Zhou L, Zhang M. Chen L, et al. Acta Otolaryngol. 2020 Feb;140(2):195-201. doi: 10.1080/00016489.2019.1700305. Epub 2019 Dec 18. Acta Otolaryngol. 2020. PMID: 31852360
Background: The various pathological types of non-squamous cell carcinomas (nSCCs) of the larynx accounted for about 5% laryngeal malignancies, but the knowledge regarding these pathological behaviors, therapeutic models and prognostic factors was limited.Objectives: To investiga …
Background: The various pathological types of non-squamous cell carcinomas (nSCCs) of the larynx accounted for about 5% laryngeal malignanci …
Differences in Merkel Cell Carcinoma Presentation and Outcomes Among Racial and Ethnic Groups.
Mohsin N, Martin MR, Reed DJ, Vilasi SM, Miao L, Hill NT, Brownell I. Mohsin N, et al. JAMA Dermatol. 2023 May 1;159(5):536-540. doi: 10.1001/jamadermatol.2023.0061. JAMA Dermatol. 2023. PMID: 36920369 Free PMC article.
IMPORTANCE: Racial and ethnic differences in skin cancer outcomes are understudied. Delineating these differences in Merkel cell carcinoma (MCC) is needed to better understand this rare disease. OBJECTIVE: To determine how MCC presentation and outcomes differ across racial …
IMPORTANCE: Racial and ethnic differences in skin cancer outcomes are understudied. Delineating these differences in Merkel cell carcinom …
Merkel cell carcinoma of the forehead area: a literature review and case report.
Caldarelli C, Autorino U, Iaquinta C, De Marchi A. Caldarelli C, et al. Oral Maxillofac Surg. 2019 Sep;23(3):365-373. doi: 10.1007/s10006-019-00793-y. Epub 2019 Jul 24. Oral Maxillofac Surg. 2019. PMID: 31342210 Review.
BACKGROUND: Merkel cell carcinoma (MCC) is an uncommon, aggressive malignancy of the skin, mostly affecting head and neck area in elderly white patients. ...Mortality and overall survival rate at five years were 28% and 24%, respectively. Spontaneous r …
BACKGROUND: Merkel cell carcinoma (MCC) is an uncommon, aggressive malignancy of the skin, mostly affecting head and …
Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
Ninomiya H, Sato Y, Inamura K, Dobashi A, Takeuchi K, Mitani H, Mun M, Nishio M, Ishikawa Y. Ninomiya H, et al. Diagn Pathol. 2024 Feb 7;19(1):27. doi: 10.1186/s13000-024-01448-7. Diagn Pathol. 2024. PMID: 38326851 Free PMC article.
CONCLUSIONS: For tumors with an ambiguous morphology, applying the neuroendocrine phenotype of NUT carcinoma may be misleading; particularly, when distinguishing it from small-cell carcinoma. Similarly, null or weak expression of squamous cell markers may be …
CONCLUSIONS: For tumors with an ambiguous morphology, applying the neuroendocrine phenotype of NUT carcinoma may be misleading …
Different outcomes in sporadic versus familial medullary thyroid cancer.
Saltiki K, Simeakis G, Anagnostou E, Zapanti E, Anastasiou E, Alevizaki M. Saltiki K, et al. Head Neck. 2019 Jan;41(1):154-161. doi: 10.1002/hed.25463. Epub 2018 Dec 11. Head Neck. 2019. PMID: 30548085
BACKGROUND: Medullary thyroid carcinoma (MTC) has varying clinical course with familial cases (fMTC) diagnosed earlier than sporadic MTC (spMTC). ...After excluding genetic screening cases, no difference in stage at diagnosis was observed. ...
BACKGROUND: Medullary thyroid carcinoma (MTC) has varying clinical course with familial cases (fMTC) diagnosed earlier than sporadic …
The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review.
Fussey JM, Vaidya B, Kim D, Clark J, Ellard S, Smith JA. Fussey JM, et al. Clin Endocrinol (Oxf). 2019 Dec;91(6):697-707. doi: 10.1111/cen.14060. Epub 2019 Jul 29. Clin Endocrinol (Oxf). 2019. PMID: 31301229
BACKGROUND: The significant variation in the clinical behaviour of sporadic medullary thyroid carcinoma (sMTC) causes uncertainty when planning the management of these patients. ...METHODS: MEDLINE and Embase databases were searched using the MeSH terms "medullary carci …
BACKGROUND: The significant variation in the clinical behaviour of sporadic medullary thyroid carcinoma (sMTC) causes uncertainty whe …
Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.
de Castroneves LA, Negrão MV, de Freitas RM, Papadia C, Lima JV Jr, Fukushima JT, Simão EF, Kulcsar MA, Tavares MR, Jorge AA, de Castro G Jr, Hoff PM, Hoff AO. de Castroneves LA, et al. Thyroid. 2016 Mar;26(3):414-9. doi: 10.1089/thy.2015.0334. Epub 2016 Feb 9. Thyroid. 2016. PMID: 26701095
BACKGROUND: Treatment of advanced medullary thyroid carcinoma (MTC) was recently improved with the approval of vandetanib and cabozantinib. ...The median PFS excluding these three patients was 12 months. Adverse events (AE) occurred in nine (75%) patients. ...
BACKGROUND: Treatment of advanced medullary thyroid carcinoma (MTC) was recently improved with the approval of vandetanib and cabozan …
Large cell neuroendocrine carcinoma of the maxillary sinus on fine needle aspiration cytology: Report of a rare case with a focus on pitfalls in diagnosis.
Kawahara A, Ono T, Sumi A, Abe H, Takase Y, Murata K, Yamaguchi T, Naito Y, Akiba J. Kawahara A, et al. Diagn Cytopathol. 2018 Feb;46(2):187-192. doi: 10.1002/dc.23814. Epub 2017 Sep 14. Diagn Cytopathol. 2018. PMID: 28905513
Head and neck large cell neuroendocrine carcinoma (LCNEC) is a rare high-grade malignant tumor with neuroendocrine differentiation. ...The pretreatment histological biopsy sample revealed tumor cells with solid growth pattern, necrotic ma …
Head and neck large cell neuroendocrine carcinoma (LCNEC) is a rare high-grade malignant tumor with ne …
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
AIRTUM Working Group; Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L. AIRTUM Working Group, et al. Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748 Free article.
Among the latter, the rare epithelial tumours of the digestive system were the most common (23%, IR: 26 per 100,000), followed by epithelial tumours of head and neck (17%, IR: 19) and rare cancers of the female genital system (17%, IR: 17), endocrine tumours …
Among the latter, the rare epithelial tumours of the digestive system were the most common (23%, IR: 26 per 100,000), followed by epithelial …
14 results